Zobrazeno 1 - 10
of 27
pro vyhledávání: '"J. Wildbrett"'
Autor:
Gabriele Siegert, T. Pinzer, J. Wildbrett, M. Breidert, S. Bergmann, Markolf Hanefeld, K. Fücker
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 105:331-335
The influence of hGH and IGF-I levels on lipid-, lipoprotein metabolism and fibrinolysis were studied in 23 patients with active acromegaly (14 women and 9 men, mean age 49.8 +/- 2.1 years) compared to a sex, BMI and age-matched control group. Mean L
Autor:
A. Patzak, Katja Fuecker, C. Köhler, Hannes Rietzsch, Sabine Fischer, Theodora Temelkova-Kurktschiev, J. Wildbrett, Markolf Hanefeld, Uta Schwanebeck
Publikováno v:
Diabetes, Obesity and Metabolism. 5:38-44
Aim: The aim of our double-blind, placebo-controlled study was to compare the effect of acarbose and glibenclamide on the insulin sensitivity in type 2 diabetes. Methods: We investigated 77 patients (mean age 58.7 years, mean BMI 27.3 kg/m2), treated
Autor:
H. J. Gaertner, S. Gromeier, Sabine Fischer, M. Nagel, Markolf Hanefeld, J. Wildbrett, F. Theissig
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 124:248-252
HISTORY AND CLINICAL FINDINGS Marked hyperinsulinism was demonstrated in the course of an oral glucose tolerance test (oGTT) in a 63-year-old woman with severe obesity (height 1.59 m, body weight 123 kg, body-mass index 46.4 kg/m2). The diabetic meta
Publikováno v:
Hormone and Metabolic Research. 27:226-230
An important feature of acromegaly is a reduced action of insulin on hepatic gluconeogenesis and peripheral glucosal disposal. Octreotide (SMS) exerts complex effects on hormonal and metabolic regulations affecting glucose homeostasis. Eight patients
Publikováno v:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 38(7)
AIMS AND METHODS Study results still conflict on the contribution of diurnal blood glucose (BG) values to Hb (A1c) in type 2 diabetes. We investigated the relationship between Hb (A1c) and diurnal BG obtained under standardized conditions - before br
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Versicherungsmedizin. 57(2)
Morbid obesity is an increasing problem in most of the industrial countries. Conservative treatment strategies are often not very effective. Because of the enormous costs and concomitant diseases of obesity, effective therapeutic strategies are manda
Autor:
S, Fischer, A, Patzak, H, Rietzsch, U, Schwanebeck, C, Köhler, J, Wildbrett, K, Fuecker, T, Temelkova-Kurktschiev, M, Hanefeld
Publikováno v:
Diabetes, obesitymetabolism. 5(1)
The aim of our double-blind, placebo-controlled study was to compare the effect of acarbose and glibenclamide on the insulin sensitivity in type 2 diabetes.We investigated 77 patients (mean age 58.7 years, mean BMI 27.3 kg/m2), treated by diet alone
Autor:
M Menschikowski, Markolf Hanefeld, S.M Haffner, Carsta Koehler, Theodora Temelkova-Kurktschiev, J. Wildbrett, Sabine Fischer
Publikováno v:
Diabetes research and clinical practice. 55(3)
In a double-blind, placebo-controlled study, we compared the effect of acarbose (A) and glibenclamide (G) on post-prandial (pp) and 24-h profiles of proinsulin and insulin.Twenty-seven patients with Type 2 diabetes mellitus insufficiently controlled
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 124(9)
Marked hyperinsulinism was demonstrated in the course of an oral glucose tolerance test (oGTT) in a 63-year-old woman with severe obesity (height 1.59 m, body weight 123 kg, body-mass index 46.4 kg/m2). The diabetic metabolic state, first diagnosed 1